Hard Bargains

By Elie Dolgin Hard bargains Gary Brouhard and his new camera. Five months after placing the orders, the cameras finally arrive. Biophysicist Gary Brouhard tears open the cardboard boxes, tosses the packaging aside, and gently places the two $47,000 cameras onto the cluttered lab bench, inconspicuously nestled between sheets of pink bubble wrap, unopened equipment boxes, and the week's growing heap of recycl

Written byElie Dolgin
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Five months after placing the orders, the cameras finally arrive. Biophysicist Gary Brouhard tears open the cardboard boxes, tosses the packaging aside, and gently places the two $47,000 cameras onto the cluttered lab bench, inconspicuously nestled between sheets of pink bubble wrap, unopened equipment boxes, and the week's growing heap of recyclables. "I don't break the boxes down as quickly as they come, so it's sort of a mess," Brouhard admits. Cleaning might not be Brouhard's forté, but he is crafty about setting up his lab on the cheap.

Brouhard, who studies single-molecule dynamics of the microtubule cytoskeleton, joined the faculty of Montreal's McGill University in August 2008. Nine months on, his lab was still very much a work in progress. Unlike most US institutions, which award new hires with generous start-up packages, Canadian universities provide little support to cover infrastructure costs. The government provides a boost, but the $750,000 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies